BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2213430)

  • 1. Rapid/automated ID methods survey. PDA Microbial ID Task Force. Parenteral Drug Association.
    J Parenter Sci Technol; 1990; 44(4):216-22. PubMed ID: 2213430
    [No Abstract]   [Full Text] [Related]  

  • 2. Report on survey of current industry gowning practices. PDA Gowning Task Force. Parenteral Drug Association.
    J Parenter Sci Technol; 1990; 44(4):223-7. PubMed ID: 2213431
    [No Abstract]   [Full Text] [Related]  

  • 3. Technical report: bioburden recovery validation. PDA Bioburden Recovery Validation Task Force. Parenteral Drug Association.
    J Parenter Sci Technol; 1990; 44(6):324-31. PubMed ID: 2277321
    [No Abstract]   [Full Text] [Related]  

  • 4. Viability-based rapid microbiological methods for sterility testing and the need for identification of contamination.
    Moldenhauer J
    PDA J Pharm Sci Technol; 2006; 60(2):81-8. PubMed ID: 16696190
    [No Abstract]   [Full Text] [Related]  

  • 5. Introduction to papers on mycoplasmology presented at a Parenteral Drug Association mycoplasma workshop.
    Potts BJ
    Biologicals; 2010 Mar; 38(2):181-2. PubMed ID: 20079662
    [No Abstract]   [Full Text] [Related]  

  • 6. Microbial identification strategies in the pharmaceutical industry.
    Cundell AM
    PDA J Pharm Sci Technol; 2006; 60(2):111-23. PubMed ID: 16696194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological indicators in the pharmaceutical and the medical device industry.
    Pflug IJ; Odlaug TE
    J Parenter Sci Technol; 1986; 40(5):242-8. PubMed ID: 3540254
    [No Abstract]   [Full Text] [Related]  

  • 8. PDA comments: PIC draft recommendations on the inspection of isolator technology. Parenteral Drug Association.
    PDA J Pharm Sci Technol; 1999; 53(3):141-7. PubMed ID: 10754704
    [No Abstract]   [Full Text] [Related]  

  • 9. PDA presentation at FDA Open Conference on Sterile Drug Manufacturing. Parenteral Drug Association.
    J Pharm Sci Technol; 1994; 48(1):4-6. PubMed ID: 8004417
    [No Abstract]   [Full Text] [Related]  

  • 10. The influence of clean room design on product contamination.
    Whyte W
    J Parenter Sci Technol; 1984; 38(3):103-8. PubMed ID: 6747777
    [No Abstract]   [Full Text] [Related]  

  • 11. Design control and validation of a facility for sterile clinical trial preparations.
    Staines L
    J Parenter Sci Technol; 1984; 38(3):109-14. PubMed ID: 6747778
    [No Abstract]   [Full Text] [Related]  

  • 12. An approach to establishing parenteral solution sterilization cycles.
    Korczynski MS; Peterson CL; Loshbaugh CC
    Bull Parenter Drug Assoc; 1974; 28(6):270-7. PubMed ID: 4455323
    [No Abstract]   [Full Text] [Related]  

  • 13. Technical Bulletin no. 2003-03: freezing of microbial samples prior to testing. Parenteral Drug Association.
    Parenteral Drug Association
    PDA J Pharm Sci Technol; 2003; 57(5):323. PubMed ID: 14677623
    [No Abstract]   [Full Text] [Related]  

  • 14. Survey on sterility testing practices.
    Akers JE; Carleton FJ; Clements WC; Woods JA
    J Parenter Sci Technol; 1987; 41(6):197-206. PubMed ID: 3437369
    [No Abstract]   [Full Text] [Related]  

  • 15. The incubation period in sterility testing.
    Bathgate H; Lazzari D; Cameron H; McKay D
    J Parenter Sci Technol; 1993; 47(5):254-7. PubMed ID: 8263662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current practices in endotoxin and pyrogen testing in biotechnology. The Quality Assurance/Quality Control Task Group. Parenteral Drug Association.
    J Parenter Sci Technol; 1990; 44(1):39-45. PubMed ID: 2313492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sterility-testing program for antibiotics and other intravenous admixtures.
    Choy FN; Lamy PP; Burkhart VD; Tenney JH
    Am J Hosp Pharm; 1982 Mar; 39(3):452-6. PubMed ID: 7041640
    [No Abstract]   [Full Text] [Related]  

  • 18. Fundamentals of a microbiological environmental monitoring program. Technical Report No. 13. PDA Environmental Task Force.
    J Parenter Sci Technol; 1990; 44 Suppl 1():S1-16. PubMed ID: 2213434
    [No Abstract]   [Full Text] [Related]  

  • 19. Validation and routine operation of a sterile dry powder filling facility.
    Prout G
    J Parenter Sci Technol; 1982; 36(5):199-204. PubMed ID: 6927748
    [No Abstract]   [Full Text] [Related]  

  • 20. Parameters governing steam sterilization of deadlegs.
    Young JH; Ferko BL; Gaber RP
    J Pharm Sci Technol; 1994; 48(3):140-7. PubMed ID: 8069515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.